Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

1.1K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.1K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

6.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.8K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

919
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
919
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

1.3K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating transcriptomics and gene-level interpretable probabilistic Tsetlin Machine reveals elevated pancreatic cancer risk in Type 2 diabetes.

Computational biology and chemistry·2026
Same author

Type 1 diabetes stigma: A UK survey of adults living with type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Co-design of an animated resource to understand inequities in access to diabetes technologies among children and young people with type 1 diabetes from ethnic minority groups and/or low socioeconomic areas.

Diabetes & metabolic syndrome·2026
Same author

Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio-economic areas.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Characterising the impact of shift work on diet and glucose variability in healthcare employees living with type 2 diabetes: The Shift-Diabetes study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Real-world glycaemic outcomes observed with the use of Medtronic 780G, Tandem Control-IQ and Omnipod 5 automated insulin delivery systems.

Diabetic medicine : a journal of the British Diabetic Association·2026

Related Experiment Video

Updated: Mar 26, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Case-Based Reasoning for Insulin Bolus Advice.

Peter Pesl1, Pau Herrero1, Monika Reddy2

  • 11 Centre for Bio-Inspired Technology, Institute of Biomedical Engineering, Imperial College London, London, UK.

Journal of Diabetes Science and Technology
|February 11, 2016
PubMed
Summary
This summary is machine-generated.

This study enhanced insulin bolus calculators for Type 1 diabetes using case-based reasoning (CBR). The Advanced Bolus Calculator for Diabetes (ABC4D) personalized insulin dosing by learning from past meals, showing promise for better glucose control.

Keywords:
bolus calculatorcase parameterscase-based-reasoningdecision supportdiabetes managementinsulin dosing algorithm

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K
Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat
11:12

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

54.6K

Related Experiment Videos

Last Updated: Mar 26, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.3K
Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat
11:12

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat

Published on: February 7, 2011

54.6K

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Endocrinology

Background:

  • Insulin bolus calculators aid Type 1 diabetes (T1D) management but lack personalization.
  • Case-based reasoning (CBR) offers a method to individualize insulin therapy by learning from past meal data.

Purpose of the Study:

  • To enhance insulin bolus calculators using CBR for personalized insulin dosing.
  • To investigate the selection, representation, and impact of case parameters in a CBR-based system (ABC4D).

Main Methods:

  • A pilot study involving 10 participants using ABC4D for 6 weeks.
  • Analysis of parameter usage (e.g., exercise, alcohol, glucose rate of change) and its effect on glycemic outcomes.
  • Participant feedback collected via a questionnaire.

Main Results:

  • Exercise and alcohol were the most utilized and preferred parameters by participants.
  • A trend towards reduced insulin dosage was observed when exercise or alcohol parameters were included.
  • Significant differences in glycemic outcomes were noted based on the pre-meal glucose rate of change.

Conclusions:

  • The study highlights the potential benefits of incorporating exercise, alcohol, and glucose rate of change parameters into insulin dosing decision support systems.
  • These parameters can improve the personalization and effectiveness of insulin therapy for individuals with T1D.